FIELD: medicine, hormones, pharmacy. SUBSTANCE: human growth hormone is used in combination with inhibitor of cortisol synthesis, in part with ketoconazole, for prophylaxis of states relating to metabolic stress (neuroendocrine syndrome). Administration can be supplemented by sexual hormone taken among testosterone and natural of synthetic estrogen. Also, invention describes the corresponding pharmaceutical compositions and kit. Invention provides the more effectively to treat states associated with metabolic syndrome. EFFECT: enhanced effectiveness of preparations and treatment. 28 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF KETOCONAZOL AND RELATED SUBSTANCES IN DRUGS USED FOR TREATMENT OF PATIENTS WITH DIABETES MELLITUS OF TYPE-II | 1994 |
|
RU2153873C2 |
METHOD FOR APPLYING CORTISOL ANTAGONISTS AT TREATING HEART FAILURE | 2000 |
|
RU2245712C2 |
METHOD FOR ENHANCING OF TESTOSTERONE AND ANALOGOUS STEROID LEVELS IN FEMALES | 2001 |
|
RU2286787C2 |
METHOD FOR DIAGNOSING METABOLIC SYNDROME AND DISEASES INCLUDING THE SYNDROME | 1996 |
|
RU2171471C2 |
APPLICATION OF AGENT WITH MODIFYING PROPERTIES IN RELATION TO HORMONES OF ADRENAL GLANDS | 2011 |
|
RU2598708C2 |
COMBINATION OF SOMATOSTATIN ANALOGUES WITH 11β-HYDROXYLASE INHIBITORS | 2013 |
|
RU2663455C2 |
DOUBLE NEUROKININ-1/NEUROKININ-3 RECEPTOR ANTAGONISTS FOR TREATING SEX HORMONE DEPENDENT DISEASES | 2016 |
|
RU2743206C2 |
METHOD FOR COMBINED USE OF INTRANASALLY ADMINISTERED INSULIN AND ORALLY ADMINISTERED METFORMIN FOR RECOVERY OF METABOLIC AND HORMONAL PARAMETERS IN TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME | 2023 |
|
RU2824275C1 |
METHOD FOR TREATING PATIENTS WITH METABOLIC SYNDROME | 2017 |
|
RU2666288C1 |
PREPARATION AND METHOD FOR THE TREATMENT OF ANDROGEN DEFICIENCY IN WOMEN, ENTOMOLOGICAL CONTAINING PROTEINS | 2015 |
|
RU2577225C1 |
Authors
Dates
2003-02-20—Published
1998-02-24—Filed